Novitium Pharma LLC recalls Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Dri…
- Recall date
- March 4, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0389-2024
- FDA classification
- Class III
- Brand / firm
- Novitium Pharma LLC
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Cross Contamination with Other Products:(mycophenolate mofetil).
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-201-20
Get recall alerts
Free email alert whenever Novitium Pharma LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Novitium Pharma LLC